Corticosteroids, behavior, and quality of life in children treated for acute lymphoblastic leukemia; a multicentered

Catherine Maude Pound1, Camillia Clark, Andy Ni

  • 1Department of Pediatrics, Division of Pediatric Medicine, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada. cpound@cheo.on.ca

Insights

High-dose corticosteroids significantly impact behavior and quality of life in children undergoing acute lymphoblastic leukemia (ALL) maintenance therapy. These effects, including emotional disturbances and increased pain, necessitate careful consideration during treatment.

Area of Science:

  • Pediatric Oncology
  • Clinical Psychology
  • Pharmacology

Background:

  • Children with acute lymphoblastic leukemia (ALL) often receive high-dose corticosteroids during maintenance therapy.
  • Corticosteroids are crucial for ALL treatment but may have significant side effects.
  • Understanding the impact on behavior and quality of life is essential for supportive care.

Purpose of the Study:

  • To investigate the effects of high-dose corticosteroids on behavior and quality of life in pediatric ALL patients during maintenance therapy.
  • To compare the effects of different corticosteroids (dexamethasone vs. prednisone) on behavior in older children.
  • To evaluate changes in behavior and quality of life when children are on versus off steroids.

Main Methods:

  • A cohort of 43 families (patient and/or parent) participated.
  • Children served as their own controls, completing questionnaires on and off steroids.
  • Validated instruments included the Child Behavior Checklist (CBCL) and the Pediatric Quality of Life Inventory (PedsQL) Cancer module.

Main Results:

  • Younger children (≤5 years) showed significantly higher CBCL scores for somatic complaints, affective problems, internalizing, externalizing, and total problems when on steroids.
  • Older children (≥6 years) exhibited higher CBCL scores for externalizing, aggressive, and oppositional defiant problems on steroids.
  • Parents reported increased pain, nausea, and procedural anxiety on PedsQL when children were on steroids; older children had greater behavioral changes with dexamethasone compared to prednisone.

Conclusions:

  • Corticosteroid treatment during ALL maintenance therapy is linked to behavioral and emotional disturbances.
  • These medications adversely affect the quality of life for children with ALL.
  • Dexamethasone is associated with more pronounced behavioral changes in older children, suggesting differential effects based on age and drug type.

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...